Jim Simons's position in BioAge Labs is currently worth $2.36M. That's 0.00% of their equity portfolio (1786th largest holding). The first BioAge Labs trade was made in Q2 2025. Since then Jim Simons bought shares two more times and sold shares on one occasions. The stake costed the investor $1.55M, netting the investor a gain of 52% so far.